Centurion Ilac Sanayi VE Ticaret AN Pharmaceutical Import Profile — Turkey (DGFT 2022–2026)

Name: Centurion Ilac Sanayi VE Ticaret AN Pharmaceutical Import Records from India — 2 Products, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Centurion Ilac Sanayi VE Ticaret AN — Pharmaceutical Importer Profile (2026) | 2 Products, $3.8M Trade | TransData Nexus

Centurion Ilac Sanayi VE Ticaret AN

Pharmaceutical Importer · Turkey · Other Focus · $3.8M Total Trade · DGFT Verified

Centurion Ilac Sanayi VE Ticaret AN is a pharmaceutical importer based in Turkey with a total trade value of $3.8M across 2 products in 2 therapeutic categories. Based on 76 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Centurion Ilac Sanayi VE Ticaret AN sources from 1 verified Indian supplier, with Indian Immunologicals Limited accounting for 100.0% of imports.

Centurion Ilac Sanayi VE Ticaret AN — Import Portfolio & Supplier Network

Centurion Ilac Sanayi VE Ticaret AN import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Centurion Ilac Sanayi VE Ticaret AN?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Indian Immunologicals Limited	$2.4M	50	100.0%

Centurion Ilac Sanayi VE Ticaret AN sources from 1 verified Indian supplier across 19 distinct formulations. The sourcing is highly concentrated — Indian Immunologicals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Abhayrab 0.5ML b.p(human rabies vaccinewith disposable syringe and diluent)	$1.3M	26
Abhayrab 0.5 ML b.p (human rabies	$200.0K	4
Abhayrab 0.5mlhuman rabies vaccine	$200.0K	4
Abhayrab 0 5ML b p human rabies vaccinewith disposable syringe and	$50.0K	1
Abhayrab 0.5ML b.p (human rabies	$50.0K	1
Abhayrab 0.5ML b.p 9(human rabies	$50.0K	1
Abhayrab 0.5ML b.p.(human rabies	$50.0K	1
Abhayrab 0.5ML(human rabies vaccine	$50.0K	1
Abhayrab 0.5ML b.p(human rabies	$50.0K	1
Abhayrab 0.5ML b.phuman rabies vaccinewith disposable syringe and	$50.0K	1
Abhayrab 0.5 ML b.p (human rabies vaccine with disposable syringe and diluent),batch no:24urab089 (vials 70011), mfg	$50.0K	1
Abhayrab 0.5 ML b.p (human rabies vaccine with disposable syringe and diluent),batch no:24urab092 & batch	$50.0K	1
Abhayrab 0.5 ML b.p (human rabies vaccine with disposable syringe and diluent),batch	$50.0K	1
Abhayrab 0.5 ML b.p (human rabies vaccine with disposable syringe and diluent),batch no:25urab002 &	$50.0K	1
Abhayrab 0.5 ML b.p (human rabies vaccine with disposable syringe and diluent),batch	$50.0K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Vaccine	Other	$2.1M	42	0.2%	13
2	Syringe	Medical Devices & Diagnostics	$1.7M	34	0.9%	6

Centurion Ilac Sanayi VE Ticaret AN imports 2 pharmaceutical products across 2 categories into Turkey totaling $3.8M.

Centurion Ilac Sanayi VE Ticaret AN — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Centurion Ilac Sanayi ve Ticaret Anonim Şirketi, commonly known as Centurion Pharma, is a privately-owned Turkish pharmaceutical company specializing in the research, development, manufacturing, and marketing of a diverse range of pharmaceutical products. Established in 1949 and incorporating Centurion, an American company, in 1999, Centurion Pharma has grown to become a significant player in the Turkish pharmaceutical industry. (centurion.com.tr)

The company operates its own manufacturing facility in Ankara, Turkey, adhering to international quality standards such as Good Manufacturing Practices (GMP). Centurion Pharma focuses on delivering high-quality, effective, and accessible medicines across various therapeutic categories, including vaccines, biosimilars, and orphan drugs. (centurion.com.tr)

2Distribution Network

Centurion Pharma's distribution network is robust, encompassing both domestic and international markets. While specific warehouse locations and logistics capabilities are not publicly detailed, the company's extensive import and export activities suggest a well-established infrastructure. Centurion Pharma imports pharmaceutical products from various countries, including India, China, Germany, the Netherlands, and Italy, indicating a broad geographic coverage.

3Industry Role

Centurion Pharma plays a multifaceted role in Turkey's pharmaceutical supply chain. As a manufacturer, it produces a wide array of pharmaceutical products, including vaccines, biosimilars, and orphan drugs. Additionally, the company imports pharmaceutical products from various countries, including India, China, Germany, the Netherlands, and Italy, indicating a broad geographic coverage. This dual role positions Centurion Pharma as both a producer and importer, contributing significantly to the availability and diversity of pharmaceutical products in the Turkish market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Centurion Ilac Sanayi VE Ticaret AN

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Centurion Pharma's sourcing strategy reveals a notable concentration in its supplier base. The company's import data indicates a significant reliance on a single supplier, Indian Immunologicals Limited, which accounts for 50 shipments valued at $2.4 million USD. This single-source dependency could pose risks related to supply chain disruptions, pricing volatility, and potential challenges in negotiating favorable terms.

The shipment data suggests a stable relationship with Indian Immunologicals Limited, as evidenced by the consistent volume and value of imports over time. However, the lack of diversification in suppliers may limit Centurion Pharma's ability to mitigate risks associated with supply chain disruptions or changes in supplier performance.

2Supply Chain Resilience

Centurion Pharma's supply chain resilience appears to be heavily dependent on its relationship with Indian Immunologicals Limited. The absence of backup suppliers for its imported products indicates a potential vulnerability to disruptions in the supply chain. Additionally, the limited diversity in imported formulations, with only 19 unique formulations, suggests a narrow product range that may not fully meet the diverse needs of the Turkish market.

The company's reliance on a single supplier and limited product diversity may expose it to risks related to supply chain disruptions, regulatory changes, or shifts in market demand. To enhance resilience, Centurion Pharma may consider diversifying its supplier base and expanding its product portfolio to better serve the evolving needs of the Turkish pharmaceutical market.

Importing Pharmaceuticals into Turkey — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Turkey

1Regulatory Authority & Framework

In Turkey, the Ministry of Health (MoH) serves as the primary regulatory authority overseeing pharmaceutical imports. The MoH enforces regulations that govern the importation, marketing, and distribution of pharmaceutical products to ensure public health and safety. Key legislation includes the Pharmaceutical and Medicinal Products Regulation, which outlines the requirements for importing pharmaceutical products, including the need for an import license and a certificate of control from the MoH.

The marketing authorization pathway for Indian generics involves obtaining approval from the MoH, which includes submitting a comprehensive dossier demonstrating the product's quality, safety, and efficacy. This process ensures that imported generics meet the standards set by Turkish authorities and are suitable for the Turkish market.

2Import Licensing & GMP

Import licensing requirements in Turkey stipulate that pharmaceutical products must be accompanied by a certificate of control issued by the MoH. This certificate is obtained prior to importation and requires documentation such as a pro forma invoice, certificate of analysis, and an approved health certificate from the country of origin. The certificate of control is valid for 12 months, ensuring that imported products meet Turkish standards.

Good Manufacturing Practice (GMP) certification is recognized by the MoH, and imported pharmaceutical products must comply with GMP standards. Indian exporters seeking to supply Centurion Pharma and the Turkish market must ensure that their manufacturing facilities are GMP-compliant to meet regulatory requirements.

Centurion Ilac Sanayi VE Ticaret AN — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Centurion Pharma's product strategy focuses on therapeutic areas such as vaccines, biosimilars, and orphan drugs. The company's import data indicates a significant investment in vaccines and medical devices, with imports valued at $2.1 million and $1.7 million USD, respectively. This focus aligns with the growing demand for immunization and specialized treatments in Turkey.

The market demand for these products is driven by factors such as an aging population, increasing prevalence of chronic diseases, and a heightened awareness of preventive healthcare. Centurion Pharma's strategic emphasis on these areas positions it to address critical healthcare needs and expand its market presence.

2Sourcing Profile

Centurion Pharma's sourcing strategy for generic drugs involves importing finished pharmaceutical formulations from countries like India. The company's reliance on a single supplier, Indian Immunologicals Limited, suggests a focused approach to procurement. This strategy may be driven by considerations such as product quality, cost-effectiveness, and supplier reliability.

India's established reputation in vaccine production and pharmaceutical manufacturing aligns with Centurion Pharma's sourcing needs, enabling the company to offer a diverse range of products to the Turkish market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Centurion Ilac Sanayi VE Ticaret AN

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Centurion Pharma, particularly in the areas of vaccines and medical devices. The company's existing relationship with Indian Immunologicals Limited demonstrates a successful sourcing model that new suppliers can emulate. However, to establish a partnership, Indian exporters must meet Centurion Pharma's quality standards, comply with Turkish regulatory requirements, and offer competitive pricing.

Gaps in Centurion Pharma's current sourcing include a limited supplier base and a narrow product portfolio. New Indian suppliers can address these gaps by providing alternative products, diversifying the supplier base, and offering innovative solutions to meet the evolving needs of the Turkish pharmaceutical market.

2Requirements & Qualifications

Indian exporters seeking to supply Centurion Pharma and the Turkish market must ensure that their manufacturing facilities are GMP-compliant. Additionally, products must meet Turkish regulatory standards, including obtaining the necessary import licenses and certificates of control from the MoH. Labeling must be in Turkish, and products should comply with batch testing, stability requirements, and serialization mandates as specified by Turkish authorities.

Frequently Asked Questions — Centurion Ilac Sanayi VE Ticaret AN

What products does Centurion Ilac Sanayi VE Ticaret AN import from India?

Centurion Ilac Sanayi VE Ticaret AN imports 2 pharmaceutical products across 2 categories. Top imports: Vaccine ($2.1M), Syringe ($1.7M).

Who supplies pharmaceuticals to Centurion Ilac Sanayi VE Ticaret AN from India?

Centurion Ilac Sanayi VE Ticaret AN sources from 1 verified Indian suppliers. The primary supplier is Indian Immunologicals Limited (100.0% of imports, $2.4M).

What is Centurion Ilac Sanayi VE Ticaret AN's total pharmaceutical import value?

Centurion Ilac Sanayi VE Ticaret AN's total pharmaceutical import value from India is $3.8M, based on 76 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Centurion Ilac Sanayi VE Ticaret AN focus on?

Centurion Ilac Sanayi VE Ticaret AN imports across 2 categories. The largest: Other (55.3%), Medical Devices & Diagnostics (44.7%).

Get Full Centurion Ilac Sanayi VE Ticaret AN Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Centurion Ilac Sanayi VE Ticaret AN

Centurion Ilac Sanayi VE Ticaret AN — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Centurion Ilac Sanayi VE Ticaret AN?

What Formulations Does Centurion Ilac Sanayi VE Ticaret AN Import?

What Products Does Centurion Ilac Sanayi VE Ticaret AN Import?

Top Products by Import Value

Centurion Ilac Sanayi VE Ticaret AN Therapeutic Categories — 2 Specializations